Insmed Inc (INSM)vsTonix Pharmaceuticals Holding Corp (TNXP)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
TNXP
Tonix Pharmaceuticals Holding Corp
$15.34
-4.60%
HEALTHCARE · Cap: $201.08M
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 4527% more annual revenue ($606.42M vs $13.11M). TNXP leads profitability with a 0.0% profit margin vs -2.1%. INSM earns a higher WallStSmart Score of 39/100 (F).
INSM
Hold39
out of 100
Grade: F
TNXP
Avoid34
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Reasonable price relative to book value
Revenue surging 108.8% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -64.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : TNXP
The strongest argument for TNXP centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 108.8% demonstrates continued momentum.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : TNXP
The primary concerns for TNXP are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
INSM profiles as a turnaround stock while TNXP is a hypergrowth play — different risk/reward profiles.
TNXP carries more volatility with a beta of 1.86 — expect wider price swings.
TNXP is growing revenue faster at 108.8% — sustainability is the question.
TNXP generates stronger free cash flow (-42M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 34/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Tonix Pharmaceuticals Holding Corp
HEALTHCARE · BIOTECHNOLOGY · USA
Tonix Pharmaceuticals Holding Corp. The company is headquartered in Chatham, New Jersey.
Visit Website →Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?